{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:42:33Z","timestamp":1794440553071,"version":"4.9.1"},"reference-count":133,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["436797"],"award-info":[{"award-number":["436797"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["491109"],"award-info":[{"award-number":["491109"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001001","name":"Alzheimer's Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Mu 1011\/14-1"],"award-info":[{"award-number":["Mu 1011\/14-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Mu1011\/15-1"],"award-info":[{"award-number":["Mu1011\/15-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.neurobiolaging.2009.04.016","type":"journal-article","created":{"date-parts":[[2009,5,23]],"date-time":"2009-05-23T04:40:26Z","timestamp":1243053626000},"page":"763-777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":448,"title":["Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease"],"prefix":"10.1016","volume":"32","author":[{"given":"Velandai","family":"Srikanth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Maczurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Westcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Juskiw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"M\u00fcnch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib1","first-page":"30406","article-title":"Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid","volume":"280","author":"Alarcon","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.braindev.2005.12.004","article-title":"Protracted juvenile neuronal ceroid lipofuscinosis\u2014an autopsy report and immunohistochemical analysis","volume":"28","author":"Anzai","year":"2006","journal-title":"Brain Dev."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(94)90131-7","article-title":"Hydrogen peroxide mediates amyloid beta protein toxicity","volume":"77","author":"Behl","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cyto.2007.11.012","article-title":"Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array","volume":"41","author":"Berbaum","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","article-title":"Understanding RAGE, the receptor for advanced glycation end products","volume":"83","author":"Bierhaus","year":"2005","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib6","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00702-008-0126-4","article-title":"Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation","volume":"115","author":"Bigl","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2337\/db07-0838","article-title":"Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes: formation of S-(2-succinyl)cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress","volume":"57","author":"Blatnik","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2990.1988.tb00864.x","article-title":"Neuropil threads occur in dendrites of tangle-bearing nerve cells","volume":"14","author":"Braak","year":"1988","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib9","first-page":"1699","article-title":"Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues","volume":"143","author":"Brett","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.46.1.223","article-title":"Advanced protein glycosylation in diabetes and aging","volume":"46","author":"Brownlee","year":"1995","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib11","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00018-002-8491-x","article-title":"RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease","volume":"59","author":"Bucciarelli","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.0954-6820.1983.tb03756.x","article-title":"Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type","volume":"213","author":"Bucht","year":"1983","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jms.517","article-title":"Acrolein-sequestering ability of endogenous dipeptides: characterization of carnosine and homocarnosine\/acrolein adducts by electrospray ionization tandem mass spectrometry","volume":"38","author":"Carini","year":"2003","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0891-5849(94)E0134-5","article-title":"Cytotoxic effects of autoxidative glycation","volume":"18","author":"Carubelli","year":"1995","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000076770","article-title":"Age-dependent expression of advanced glycation end product receptor genes in the human heart","volume":"50","author":"Casselmann","year":"2004","journal-title":"Gerontology"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2174\/156652407783220741","article-title":"RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease","volume":"7","author":"Chen","year":"2007","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib17","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1523\/JNEUROSCI.0035-05.2005","article-title":"The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia","volume":"25","author":"Cho","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib18","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1471-4159.2004.02609.x","article-title":"Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration","volume":"90","author":"Chou","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/156652407783220714","article-title":"Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response","volume":"7","author":"Clynes","year":"2007","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib20","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.1042\/bst021097s","article-title":"The role of bound lipid and transition metal in the formation of fluorescent advanced glycation endproducts by human serum albumin","volume":"21","author":"Cochrane","year":"1993","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib21","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/01.WCB.0000090622.86921.0E","article-title":"Advanced glycation endproducts induce changes in glucose consumption, lactate production, and ATP levels in SH-SY5Y neuroblastoma cells by a redox-sensitive mechanism","volume":"23","author":"de Arriba","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib22","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood\u2013brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(01)02174-7","article-title":"Advanced glycation endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism","volume":"312","author":"Deuther-Conrad","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1357-2725(01)00046-2","article-title":"S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles","volume":"33","author":"Donato","year":"2001","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00296-004-0456-y","article-title":"Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis","volume":"25","author":"Drinda","year":"2004","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib27","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI18127","article-title":"Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells","volume":"112","author":"Du","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib28","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1073\/pnas.94.10.5296","article-title":"Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease","volume":"94","author":"Du Yan","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib29","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1046\/j.1471-4159.2003.01988.x","article-title":"Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs)","volume":"87","author":"Dukic-Stefanovic","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1471-4159.2003.01988.x","article-title":"Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs)","volume":"87","author":"Dukic-Stefanovic","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib31","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1001\/archneur.62.11.1734","article-title":"Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia","volume":"62","author":"Emanuele","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib32","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.ATV.0000160342.20342.00","article-title":"Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men","volume":"25","author":"Falcone","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00726-006-0409-8","article-title":"Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects","volume":"32","author":"Fonteh","year":"2007","journal-title":"Amino Acids"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/13813450701602523","article-title":"Advanced glycation endproducts influence the mRNA expression of RAGE RANKL and various osteoblastic genes in human osteoblasts","volume":"113","author":"Franke","year":"2007","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib35","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/0006-3223(91)90158-I","article-title":"Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type","volume":"30","author":"Fujisawa","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s003910170018","article-title":"Protein \u201cAGEing\u201d\u2014cytotoxicity of a glycated protein increases with its degree of AGE-modification","volume":"34","author":"Gasic-Milenkovic","year":"2001","journal-title":"Z. Gerontol. Geriatr."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib37","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1460-9568.2003.02506.x","article-title":"beta-Amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon-gamma and \u2018advanced glycation endproducts\u2019 in a murine microglia cell line","volume":"17","author":"Gasic-Milenkovic","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/092986608784246515","article-title":"Advanced glycation: implications in tissue damage and disease","volume":"15","author":"Gasser","year":"2008","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib39","first-page":"276","article-title":"Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis","volume":"54","author":"Gerdemann","year":"2000","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib40","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/01.hjh.0000177535.45785.64","article-title":"Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension","volume":"23","author":"Geroldi","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib41","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2174\/092986706777585013","article-title":"Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target","volume":"13","author":"Geroldi","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib42","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00702-008-0069-9","article-title":"Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment","volume":"115","author":"Ghidoni","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib43","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.freeradbiomed.2004.02.006","article-title":"N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease","volume":"36","author":"Girones","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.diabres.2008.04.013","article-title":"Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function","volume":"81","author":"Gohda","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib45","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0165-0173(01)00055-8","article-title":"Tau and transgenic animal models","volume":"35","author":"Gotz","year":"2001","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib46","doi-asserted-by":"crossref","first-page":"17741","DOI":"10.1016\/S0021-9258(17)32503-6","article-title":"Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor","volume":"269","author":"Haass","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4020-6191-2_5","article-title":"Pathologies involving the S100 proteins and RAGE","volume":"45","author":"Heizmann","year":"2007","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib48","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice","volume":"28","author":"Hickman","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3233\/JAD-2007-11210","article-title":"Could carnosine or related structures suppress Alzheimer's disease?","volume":"11","author":"Hipkiss","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/bbrc.1997.6944","article-title":"Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons","volume":"236","author":"Horie","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib51","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s007020050067","article-title":"Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis","volume":"105","author":"Hoyer","year":"1998","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4419-8969-7_8","article-title":"Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications","volume":"541","author":"Hoyer","year":"2004","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib53","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.abb.2003.08.030","article-title":"Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders","volume":"419","author":"Hudson","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib54","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1096\/fj.07-9909com","article-title":"Identification, classification, and expression of RAGE gene splice variants","volume":"22","author":"Hudson","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2840-6-9","article-title":"Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes","volume":"6","author":"Humpert","year":"2007","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib56","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bbrc.2004.07.026","article-title":"Effect of carbonyl compounds on red blood cells deformability","volume":"321","author":"Iwata","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.abb.2003.08.017","article-title":"Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease","volume":"419","author":"Jerums","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib58","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2174\/156720508785908937","article-title":"Evidence for altered LRP\/RAGE expression in Alzheimer lesion pathogenesis","volume":"5","author":"Jeynes","year":"2008","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib59","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/00001756-199504190-00010","article-title":"Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease?","volume":"6","author":"Kimura","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib60","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0006-8993(99)01415-8","article-title":"An immunochemical study on tau glycation in paired helical filaments","volume":"830","author":"Ko","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib61","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/er.2007-0034","article-title":"Cognitive dysfunction and diabetes mellitus","volume":"29","author":"Kodl","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib62","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00702-003-0038-2","article-title":"Differential effects of \u201cAdvanced glycation endproducts\u201d and beta-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y","volume":"111","author":"Kuhla","year":"2004","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib63","doi-asserted-by":"crossref","first-page":"21614","DOI":"10.1016\/S0021-9258(17)31849-5","article-title":"Analysis of microtubule-associated protein tau glycation in paired helical filaments","volume":"269","author":"Ledesma","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib64","doi-asserted-by":"crossref","first-page":"15396","DOI":"10.1021\/bi971071m","article-title":"Mutations in the transmembrane domain of APP altering gamma-secretase specificity","volume":"36","author":"Lichtenthaler","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib65","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s007020050108","article-title":"Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress","volume":"105","author":"Loske","year":"1998","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib66","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1046\/j.1432-1327.2000.01452.x","article-title":"Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide","volume":"267","author":"Loske","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib67","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer's disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/exnr.2001.7732","article-title":"Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism","volume":"171","author":"Lue","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib70","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/cercor\/bhh123","article-title":"Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains","volume":"15","author":"L\u00fcth","year":"2005","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1537-1891(02)00198-2","article-title":"Circulating amyloid-beta peptide crosses the blood\u2013brain barrier in aged monkeys and contributes to Alzheimer's disease lesions","volume":"38","author":"Mackic","year":"2002","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib72","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(96)12462-9","article-title":"Blood\u2013brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs","volume":"206","author":"Martel","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib73","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1074\/jbc.272.7.4037","article-title":"Accumulation of pyrraline-modified albumin in phagocytes due to reduced degradation by lysosomal enzymes","volume":"272","author":"Miyata","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib74","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.6779377","article-title":"Nonenzymatic browning in vivo: possible process for aging of long-lived proteins","volume":"211","author":"Monnier","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib75","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bbagrm.2008.06.012","article-title":"Recognition and elimination of nonsense mRNA","volume":"1779","author":"Muhlemann","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib76","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0006-291X(05)80875-7","article-title":"Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes","volume":"173","author":"Mullarkey","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib77","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0925-4439(96)00062-2","article-title":"Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide","volume":"1360","author":"M\u00fcnch","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib78","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0165-0173(96)00016-1","article-title":"Advanced glycation endproducts in ageing and Alzheimer's disease","volume":"23","author":"M\u00fcnch","year":"1997","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib79","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/13704","article-title":"Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library","volume":"17","author":"M\u00fcnch","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib80","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/mnfr.200600254","article-title":"Coffee and Maillard products activate NF-kappaB in macrophages via H(2)O(2) production","volume":"51","author":"Muscat","year":"2007","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib81","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2119\/2006-00090.Nakamura","article-title":"Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes","volume":"13","author":"Nakamura","year":"2007","journal-title":"Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib82","doi-asserted-by":"crossref","first-page":"14998","DOI":"10.1016\/S0021-9258(18)42138-2","article-title":"Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins","volume":"267","author":"Neeper","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib83","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neulet.2007.02.013","article-title":"PKC delta and NADPH oxidase in AGE-induced neuronal death","volume":"416","author":"Nitti","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib84","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/bbrc.1998.8401","article-title":"The generation of superoxide anions in glycation reactions with sugars, osones, and 3-deoxyosones","volume":"245","author":"Ortwerth","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib85","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam Study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"issue":"13 Suppl.","key":"10.1016\/j.neurobiolaging.2009.04.016_bib86","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/0278-5846(89)90112-7","article-title":"Nootropic drugs and brain cholinergic mechanisms","author":"Pepeu","year":"1989","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib87","doi-asserted-by":"crossref","first-page":"48967","DOI":"10.1074\/jbc.M108196200","article-title":"Chelating activity of advanced glycation end-product inhibitors","volume":"276","author":"Price","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib88","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0009-8981(00)00327-2","article-title":"Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation","volume":"301","author":"Rahbar","year":"2000","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib89","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1006\/mcbr.2000.0239","article-title":"Novel inhibitors of advanced glycation endproducts (part II)","volume":"3","author":"Rahbar","year":"2000","journal-title":"Mol. Cell Biol. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib90","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1096\/fj.08-109033","article-title":"A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)","volume":"22","author":"Raucci","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib91","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2174\/156652407783220750","article-title":"RAGE as a receptor of HMGB1 (Amphoterin): roles in health and disease","volume":"7","author":"Rauvala","year":"2007","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib92","first-page":"pe12","article-title":"Carnosine: a versatile antioxidant and antiglycating agent","author":"Reddy","year":"2005","journal-title":"Sci. Aging Knowledge Environ."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib93","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0074-7742(07)82012-5","article-title":"Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?","volume":"82","author":"Rogers","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib94","first-page":"43","article-title":"Psychophysiological research in psychiatry and neuropsychopharmacology II. The investigation of antihypoxidotic\/nootropic drugs (tenilsetam and co-dergocrine-mesylate) in elderlies with the Viennese Psychophysiological Test-System (VPTS)","volume":"11","author":"Saletu","year":"1989","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib95","first-page":"217","article-title":"Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach","author":"Salkovic-Petrisic","year":"2007","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib96","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0002-9440(10)65659-3","article-title":"Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases","volume":"153","author":"Sasaki","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib97","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1073\/pnas.91.19.8807","article-title":"Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins","volume":"91","author":"Schmidt","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib98","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2174\/0929867054367130","article-title":"Drug development and PET-diagnostics for Alzheimer's disease","volume":"12","author":"Schmidt","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib99","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.arr.2005.02.003","article-title":"Glucose metabolism and Alzheimer's disease","volume":"4","author":"Schubert","year":"2005","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib100","first-page":"1051","article-title":"Advanced glycated albumin impairs protein degradation in the kidney proximal tubules cell line LLC-PK1","volume":"44","author":"Sebekova","year":"1998","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib101","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1210\/endo.138.5.5151","article-title":"Inhibitory effects of tenilsetam on the Maillard reaction","volume":"138","author":"Shoda","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib102","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","article-title":"Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease","volume":"49","author":"Simard","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib103","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0306-9877(94)90132-5","article-title":"Alzheimer disease: an imbalance of proteolytic regulation?","volume":"42","author":"Smith","year":"1994","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib104","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/00001756-199508000-00001","article-title":"Amyloidosis, advanced glycation end products and Alzheimer disease","volume":"6","author":"Smith","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00403972","article-title":"Diabetes mellitus and Alzheimer's disease: glycation as a biochemical link","volume":"39","author":"Smith","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib106","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0304-3940(96)13100-1","article-title":"Early contribution of oxidative glycation in Alzheimer disease","volume":"217","author":"Smith","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib107","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.exger.2006.06.002","article-title":"The molecular basis of the prevention of Alzheimer's disease through healthy nutrition","volume":"42","author":"Steele","year":"2007","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib108","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/1352458507088105","article-title":"Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity","volume":"14","author":"Sternberg","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib109","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.freeradbiomed.2005.10.061","article-title":"Degradation of glycated bovine serum albumin in microglial cells","volume":"40","author":"Stolzing","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib110","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1006\/geno.1994.1517","article-title":"Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3","volume":"23","author":"Sugaya","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib111","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(96)13275-4","article-title":"Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain","volume":"221","author":"Takedo","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib112","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/138161208784139693","article-title":"Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease","volume":"14","author":"Takeuchi","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib113","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0925-4439(98)00031-3","article-title":"Presenilin-1 mutations associated with familial Alzheimer's disease do not disrupt protein transport from the endoplasmic reticulum to the Golgi apparatus","volume":"1407","author":"Tan","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib114","doi-asserted-by":"crossref","first-page":"25781","DOI":"10.1074\/jbc.M001235200","article-title":"The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells","volume":"275","author":"Tanaka","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/1389450054021873","article-title":"The role of AGEs and AGE inhibitors in diabetic cardiovascular disease","volume":"6","author":"Thomas","year":"2005","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib116","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.abb.2003.08.013","article-title":"Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts","volume":"419","author":"Thornalley","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib117","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00002512-199609020-00001","article-title":"Role of the Maillard reaction in diabetes mellitus and diseases of aging","volume":"9","author":"Thorpe","year":"1996","journal-title":"Drugs Aging"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib118","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2174\/156652407783220705","article-title":"RAGE, diabetes, and the nervous system","volume":"7","author":"Toth","year":"2007","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib119","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0006-8993(94)91736-1","article-title":"Amyloid beta protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid beta protein","volume":"639","author":"Ueda","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib120","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.91.11.4766","article-title":"Advanced glycation end products contribute to amyloidosis in Alzheimer disease","volume":"91","author":"Vitek","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib121","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0531-5565(02)00005-0","article-title":"Oxidative DNA damage as a marker of aging in WI-38 human fibroblasts","volume":"37","author":"Wolf","year":"2002","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib122","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1046\/j.0953-816x.2001.01820.x","article-title":"Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia","volume":"14","author":"Wong","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib123","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1074\/jbc.272.12.7977","article-title":"Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins","volume":"272","author":"Xia","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib124","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.1073\/pnas.91.16.7787","article-title":"Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress","volume":"91","author":"Yan","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib125","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib126","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib127","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0022-3956(02)00020-1","article-title":"Modeling the prevalence and incidence of Alzheimer's disease and mild cognitive impairment","volume":"36","author":"Yesavage","year":"2002","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib128","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1042\/bj20021371","article-title":"Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury","volume":"370","author":"Yonekura","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib129","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.20045","article-title":"Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice","volume":"39","author":"Zeng","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib130","doi-asserted-by":"crossref","first-page":"35507","DOI":"10.1074\/jbc.M806948200","article-title":"Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases","volume":"283","author":"Zhang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib131","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nurt.2008.05.011","article-title":"New therapeutic targets in the neurovascular pathway in Alzheimer's disease","volume":"5","author":"Zlokovic","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib132","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0006-8993(85)90423-8","article-title":"Blood\u2013brain barrier permeability to leucine-enkephalin d-alanine2-d-leucine5-enkephalin and their N-terminal amino acid (tyrosine)","volume":"336","author":"Zlokovic","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2009.04.016_bib133","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1471-4159.1989.tb08522.x","article-title":"Kinetic analysis of leucine-enkephalin cellular uptake at the luminal side of the blood\u2013brain barrier of an in situ perfused guinea-pig brain","volume":"53","author":"Zlokovic","year":"1989","journal-title":"J. Neurochem."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458009001432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458009001432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:18:55Z","timestamp":1759317535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458009001432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":133,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0197458009001432"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.04.016","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}